We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Privacy Terms and Cookie Policy
Shining Light on Farm & Food Policy for 20 Years.
Friday, September 27, 2024
Bayer says it’s looking to restructure its business and trim management after reporting poor financial results for the latest quarter, largely driven by the performance of its Crop Science Division.
A label required by the state of California warning of glyphosate’s potential as a human carcinogen is unconstitutional, the 9th Circuit Court of Appeals concluded in a decision that could aid Bayer in its ongoing legal battle over Roundup.
Leaders of the Senate Agriculture Committee are working together to get a year-long extension of the 2018 farm bill included in a new continuing resolution that will be needed to keep the government funded after Nov. 17.
Bayer said it will appeal a jury verdict from a local court in Philadelphia awarding $175 million, including $150 million in punitive damages,to an 83-year-old city resident who claimed exposure to Roundup caused his cancer.
A European Food Safety Authority review did not find “any critical areas of concern” in a peer review it conducted of a risk assessment of glyphosate, the active ingredient in Roundup, as the European Union prepares to vote later this year on the future of the herbicide on the continent.
Bayer is hailing a decision by the 11th Circuit Court of Appeals to reconsider its judgment in a case involving the question of whether federal pesticide law trumps state failure-to-warn claims.
Higher herbicide prices driven by supply shortages helped drive Bayer earnings above analysts’ estimates for the third quarter, as the company’s crop science division achieved an overall sales increase of 8.4% from the third quarter in 2021, to more than $4.7 billion.
